Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection

© 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC..

Recent findings in permanent cell lines suggested that SARS-CoV-2 Omicron BA.1 induces a stronger interferon response than Delta. Here, we show that BA.1 and BA.5 but not Delta induce an antiviral state in air-liquid interface cultures of primary human bronchial epithelial cells and primary human monocytes. Both Omicron subvariants caused the production of biologically active types I (α/β) and III (λ) interferons and protected cells from super-infection with influenza A viruses. Notably, abortive Omicron infection of monocytes was sufficient to protect monocytes from influenza A virus infection. Interestingly, while influenza-like illnesses surged during the Delta wave in England, their spread rapidly declined upon the emergence of Omicron. Mechanistically, Omicron-induced interferon signaling was mediated via double-stranded RNA recognition by MDA5, as MDA5 knockout prevented it. The JAK/STAT inhibitor baricitinib inhibited the Omicron-mediated antiviral response, suggesting it is caused by MDA5-mediated interferon production, which activates interferon receptors that then trigger JAK/STAT signaling. In conclusion, our study (1) demonstrates that only Omicron but not Delta induces a substantial interferon response in physiologically relevant models, (2) shows that Omicron infection protects cells from influenza A virus super-infection, and (3) indicates that BA.1 and BA.5 induce comparable antiviral states.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:95

Enthalten in:

Journal of medical virology - 95(2023), 3 vom: 04. März, Seite e28686

Sprache:

Englisch

Beteiligte Personen:

Bojkova, Denisa [VerfasserIn]
Bechtel, Marco [VerfasserIn]
Rothenburger, Tamara [VerfasserIn]
Kandler, Joshua D [VerfasserIn]
Hayes, Lauren [VerfasserIn]
Olmer, Ruth [VerfasserIn]
Martin, Ulrich [VerfasserIn]
Jonigk, Danny [VerfasserIn]
Ciesek, Sandra [VerfasserIn]
Wass, Mark N [VerfasserIn]
Michaelis, Martin [VerfasserIn]
Cinatl, Jindrich [VerfasserIn]

Links:

Volltext

Themen:

9008-11-1
Antiviral Agents
Antiviral state
BA.1
BA.5
COVID-19
Delta
Influenza
Interferon
Interferons
Janus Kinase Inhibitors
Journal Article
Monocytes
Research Support, Non-U.S. Gov't
SARS-CoV-2
Super-infection

Anmerkungen:

Date Completed 30.03.2023

Date Revised 19.06.2023

published: Print

Citation Status MEDLINE

doi:

10.1002/jmv.28686

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM354443836